Drugs / CPX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004428 | Sep 1997 → Oct 1999 | cystic fibrosis | FDA Office of Orphan Products Development | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004428 ↗ |
| Route | Oral | “each treated with a different oral dose of CPX or placebo” NCT00004428 ↗ |